New trial seeks to improve sharing of genetic colorectal cancer risks
Business Announcement
Updates every hour. Last Updated: 22-Jun-2026 11:16 ET (22-Jun-2026 15:16 GMT/UTC)
In time for Colorectal Cancer Awareness Month in March, the Alliance for Clinical Trials in Oncology has launched a new clinical study aimed at helping improve how patients with colorectal cancer share information about the genetic risks to their family members. Supported by grants from the National Cancer Institute, the trial, “Family Communications After Genetic Testing,” seeks to enroll about 4,000 colorectal cancer patients and their at-risk relatives across the United States.
Researchers have discovered that non-psychoactive cannabis compounds, CBD and CBG, can significantly reduce liver fat and improve metabolic health. The study reveals that these compounds work by creating a backup energy reserve in the liver and restoring the activity of cellular "cleaning crews" to break down harmful waste. These findings highlight a new, plant-based path for treating the world’s most common chronic liver disorder.
Improving the gap between your biological age and your chronological age is associated with a lower risk of stroke and improvements in signs of damage in the brain, according to a preliminary study released March 5, 2026, that will be presented at the American Academy of Neurology’s 78th Annual Meeting taking place April 18-22, 2026, in Chicago and online.